CTRI/2024/02/062644尚未招募Unknown
Prospective, Interventional, Proof-of-Science, Randomised, Evaluator-Blinded, In-Use Safety and Efficacy Study of Two Moisturising Creams in Wound-Healing. - NI
S H Kelkar and Company Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. The subject is aged between 18 and 55 years (both inclusive) at the time of informed consent.
- •2. The subject is a non-pregnant, non-lactating healthy adult female.
- •3. No previous history of adverse skin conditions, and not under any medication likely to interfere with the results.
- •4. The subject has a self-reported negative urine pregnancy test.
- •5. The subject is in a good general health as determined from recent medical history.
- •6. The subject has willingness and ability to adhere to study directions, and agrees not to use any other skin creams, lotions, serums, etc. at the application sites, except for the specified test products, and return for all specified visits.
- •7. The subject possesses the ability to comprehend and provide written informed consent for participation in the study.
排除标准
- •1. The subject is currently pregnant or lactating or is planning to become pregnant during the study period.
- •2. The subject has a history of allergies or specific allergic reactions upon using dermatological or cosmetic products.
- •3. The subject is currently enrolled in an active investigational study or has participated in an investigational study within 30 days prior to enrolment.
- •4. The subject suffers from any active clinically significant disease or any condition that according to the discretion of the investigator warrants exclusion from the study.
- •5. The subject is taking or has taken a medication which, in the judgement of the Investigator, makes the subject ineligible or places the subject at undue risk.
研究者
相似试验
进行中(未招募)
Unknown
Effects and Implementation of the ACT Program in CearáRBR-5gbhw5wFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
已完成
不适用
A clinical study to assess the safety and effectiveness of different dosages of the same collagen peptide and different collagen peptide-containing test treatments in adult human subjectsCTRI/2022/11/047149Collagen Lifesciences Private Limited264
已完成
不适用
A Clinical Study to evaluate the effectiveness of Jolly Tulsi 51 drops for Boosting Immune system and Detoxification in healthy subjects.CTRI/2018/02/012126Jolly Health Care30
招募中
3 期
Prospective, randomized, pharmacological intervention study; evaluating the effect of the angiotensin II-receptor (AT1) blocker candesartan versus placebo in prevention of trastuzumab-associated cardiotoxicity in patients with primary breast cancer treated with trastuzumabdecrease of the left ventricular ejection fraction (LVEF)1001928010027656NL-OMON34077Antoni van Leeuwenhoek Ziekenhuis160
进行中(未招募)
不适用
Prospective, randomized, pharmacological intervention study; evaluating the effect of the angiotensin II-receptor (AT1) blocker candesartan versus placebo in prevention of trastuzumab-associated cardiotoxicity in patients with primary breast cancer treated with trastuzumab - M06HERWHO: 0-2 Serum creatinine <140 umol/l Thyroid stimulating hormone between 0.5-3.9 MU/l. Blood pressure systolic = 140 mmHg diastolic = 90 mmHg is acceptable at randomization. LVEF ? 50% assessed by multigated angiography (MUGA) or cardiac ultrasoundEUCTR2006-001707-11-NLKI-Av
